Conrad Chan


Conrad Chan
Partner

Contact Information

Direct Dial: (852) 3582 3212
Mobile: (852) 9098 8975
Email: conrad.chan@kyclaw.com

Languages Spoken

  • English
  • Cantonese
  • Putonghua

Education

  • Bachelor of Laws, University of Hong Kong
  • Bachelor of Laws, University of Peking, China

Admissions

  • Hong Kong SAR

Bio

Conrad Chan is a founding partner of our firm and was previously a partner of an international firm.

Conrad specialises in advising on cross-border mergers and acquisitions (public and private), private equity transactions, insolvency / corporate workouts and debt restructuring, listings and public offerings, capital markets transactions (debt and equity), securities regulatory compliance / investigation, joint ventures and other commercial transactions across various jurisdictions. He frequently acts for and advises multinational, China, Southeast Asia and Hong Kong enterprises and financial institutions on a wide range of matters. He is regularly rated as one of the leading lawyers in the areas of Capital Markets, Corporate / M&A and Private Equity.

He has extensive experience across a wide variety of industry sectors including financial services and funds, pharmaceuticals and healthcare, TMT, real estate, mining, energy and natural resources, and trading, retail and manufacturing.

Conrad is regularly ranked as a leading lawyer in many different areas, some of which are:

  • “Recommended Lawyer” (Who’s Who Legal – Mainland China, Hong Kong & Macau SAR – Capital Markets 2024)
  • “Leading lawyer, Commercial, Corporate and M&A” (The Legal 500 Asia Pacific 2023/2024)
  • “Highly regarded, Leading Lawyer” (IFLR 1000, 2018-2024)
  • “Ranked Lawyer, Corporate/M&A: Independent Hong Kong Firms – China” (Chambers 2022/2023/2024)
  • “Recommended Lawyer” (Who’s Who Legal: Global Leader – Capital Markets – Debt & Equity 2021/2023)
  • “Recommended Lawyer” (Who’s Who Legal: National Leader – Mainland China & Hong Kong SAR – Capital Markets 2021/2023)
  • “Distinguished practitioner, Capital Markets, Corporate and M&A” (asialaw Profiles 1999/2020, 2022/2023, 2023/2024, 2024/2025)
  • “Leading Lawyer” (Who’s Who Legal: Capital Markets 2017/2020)
  • “Leading Lawyer, Financial & Corporate” (IFLR 1000, 2016/2017)
  • “Leading Lawyer, China, Corporate/M&A: Hong Kong-based (International Firms)” (Chambers Global, 2014)
  • “Leading Lawyer, Corporate/M&A: Hong Kong-based” (Chambers Asia Pacific, 2013)
  • ”Leading Lawyer, Capital markets – equity” (IFLR1000, 2013)
  • “Leading Lawyer, Mergers & Acquisitions” (IFLR1000, 2013)
  • “Leading Lawyer, Private Equity” (IFLR1000, 2013)
  • “Leading lawyer, Corporate/M&A: High-end Capability” (Chambers Asia Pacific, 2012)

Conrad is currently a member of the Board of Directors of the Hong Kong Science and Technology Parks Corporation, a member of the Listing Committee of The Hong Kong Stock Exchange of Hong Kong Limited, the Takeovers and Mergers Panel, and of the Takeovers Appeals Committee of the Securities and Futures Commission of Hong Kong (SFC). He also sits on the Solicitors’ Disciplinary Tribunal (as Tribunal Convenor) and the Appeal Panel (Housing) under the Housing Ordinance.  He was formerly a member of the Listing Review Committee of The Hong Kong Stock Exchange of Hong Kong Limited.

Recent Transactions

  • Hidili Industry International – debt restructuring regarding offshore creditors involving holders of the senior notes listed on SGX and onshore creditors in the PRC. The offshore restructuring involves the issue of new shares and zero-coupon bonds to the offshore creditors and placement arrangement of the new shares by Hidili for and on behalf of the offshore creditors implemented by way of a scheme of arrangement between Hidili and the offshore creditors and a recognition order granted by the US Bankruptcy Court
  • Hsin Chong Aster Building Services – creditors’ scheme of arrangement discharging about HKD 4.38 billion of indebtedness involving bank loans and USD senior notes and the associated corporate restructuring upon successful execution of the creditors’ scheme
  • SkinCentral/UMP Medical – representing a dermatology specialist in the disposal of her majority stake in a very reputable dermatology specialist clinic to UMP Medical Centre Limited for HKD 100 million
  • China Huarong Energy Company Limited – disposal of liabilities, debt restructuring and issue of convertible preference shares
  • Shanghai Realway Capital Assets Management – representing Alliance Capital Partner and the underwriters (Yuexiu Securities, Alliance Capital, Guosen Securities and SPDB International) in the IPO and listing of H-shares of Shanghai Realway, the first Mainland private equity fund manager having its H-shares listed on the Main Board of the Hong Kong Stock Exchange
  • Representing the offeror to acquire a controlling stake in Interactive Entertainment China Cultural Technology and a mandatory general offer for all its shares
  • Advised S. Culture International Holdings Limited, a renowned distributor and retailer of lifestyle comfort footwear products in Hong Kong, on a takeover by PRC based Shang Ying Financial Holding Co. Limited and also on a “special deal” under the Takeovers Code
  • Advised Handsome Global Investments Limited as the offeror in acquiring a majority stake in the HKEx listed China Hanya Group Holdings Limited, and in launching a takeover bid for all the shares in China Hanya
  • UDL Holdings Ltd. – representing the offeror in acquiring a controlling stake in UDL Holdings Ltd. and a mandatory general offer in the aggregate amount of approximately HKD453.97 million
  • Stock Exchange disciplinary proceedings – Representing the Chairman of a Main Board listed issuer in a disciplinary proceedings and successfully defending against a proposed sanction under Rule 2A.09(7) of the Listing Rules (a public statement that the retention of office by the Chairman is prejudicial to the interests of investors)
  • De-listing/cancellation of listing under Main Board Rule 13.24 – representing Main Board issuers in relation to “sufficiency of operations” and making submissions to the Stock Exchange
  • China Nuclear Industry – takeover bid for Tack Hsin
  • Forebase International Holdings Limited – issue of the 13% senior guaranteed secured notes due 2014 with aggregate principal amount of up to US$15 million to a subsidiary of CCBI
  • Frasers – privatisation of Frasers by way of a scheme of arrangement for approximately HKD546 million and a takeover bid of Frasers for approximately HKD1,343 million
  • Hidili Industry International Development Limited – acquisition of 100% equity interest in Panzhihua City Huixing Industry and Commercial Co., Ltd and Panzhihua City Luhuan Industry and Commercial Co., Ltd
  • ICBC International Investment Management Limited – Investment by ICBCI into Prosperity International (H.K.) Limited by way of two secured fixed-coupon convertible notes
  • Livzon Pharmaceutical Group Inc. – listing of overseas listed foreign shares by way of introduction on the Main Board of the Stock Exchange via conversion of Shenzhen-listed B shares into Hong Kong-listed H shares
  • Mongolian Mining Corporation (MMC) – representing MMC in its Main Board listing and USD 6,450 million global offering. This was the largest private coking coal producer in Mongolia and the first mineral company listing (Main Board) under the current Chapter 18
  • Representing issuers and sponsors/underwriters in various Main Board and GEM IPOs, including Wing Lee Development Construction Holdings, Boardware Intelligence Technology, China Saftower, SMC Electric, Cirtek Holdings, JiaChen Holding Group, Kwung’s Holdings, Home Control International, Shanghai Realway Capital Assets Management, Xinyi Automobile Glass Hong Kong, Vistars Holdings, Tak Lee Machinery, ECI Technology, i-Control, Anacle Systems, PFC Device, L&A International, Telefield, Asian Citrus and CVM Minerals
  • Shell Electric – a voluntary general offer of all its shares by China Overseas Land for over HK$2,600 million